Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone morphogenetic protein 10 (BMP10) is a member of the TGF-β superfamily and plays a critical role in cardiac development, particularly in the trabeculation of the heart during embryogenesis. It is essential for maintaining proliferative activity in embryonic cardiomyocytes. BMP10 acts as an atrial-specific biomarker regulated by PITX2 transcription factor and is a novel biomarker for cardiovascular diseases. It binds specifically to activin receptor-like kinase 1 (ALK1), mediating endothelial signaling. It may function as a tumor suppressor in cancer research, especially breast cancer.
ALK1 receptor signaling modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone Morphogenetic Protein 10 (BMP10).